Home>Topics>Stocks>NPS Pharmaceuticals

NPS Pharmaceuticals NPSP

  1. All
  2. Commentary
  3. Headlines
    1. Shire shares jump as drug approval vindicates $5.2 bln NPS purchase

      Headlines

      Mon, 26 Jan 2015

      LONDON, Jan 26 (Reuters) - Shire Plc shares gained more than 3 percent on Monday following news U.S. regulators had approved NPS Pharmaceuticals Inc's drug Natpara, validating Shire's decision to buy...

    2. UPDATE 1-U.S. FDA approves NPS drug, in move validating Shire takeover deal

      Headlines

      Fri, 23 Jan 2015

      Jan 23 (Reuters) - The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc's drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc , which recently agreed to acquire NPS for $5.2 billion.

    3. FDA approves NPS drug, in move validating Shire takeover deal

      Headlines

      Fri, 23 Jan 2015

      Jan 23 (Reuters) - The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc.'s drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc , which recently agreed...

    4. Shire to buy NPS for $5.2 billion to boost rare disease drugs

      Headlines

      Mon, 12 Jan 2015

      LONDON (Reuters) - Shire Plc has agreed to buy U.S. group NPS Pharmaceuticals Inc for $5.2 billion, the Dublin-based drugmaker's biggest acquisition yet as it seeks to strengthen its position in the lucrative field of medicines for rare diseases.

    5. Rise in healthcare stocks lifts European equities

      Headlines

      Mon, 12 Jan 2015

      LONDON, Jan 12 (Reuters) - A rise in healthcare shares, following renewed signs of industry consolidation after Shire Plc agreed to buy NPS Pharmaceuticals for $5.2 billion, lifted European equities...

    6. Shire’s Acquisition of NPS Pharma Adds to its Moaty Rare Disease Portfolio; Increasing FVE Modestly

      Commentary

      Sun, 11 Jan 2015

      We anticipate increasing Shire’s FVE by about 5% following its agreement to acquire NPS Pharmaceuticals for $5.2 billion in cash (or $46 per share). We think it reinforces Shire's narrow economic moat, as the deal will add

    7. Shire to buy NPS for $5.2 billion to boost rare disease drugs

      Headlines

      Sun, 11 Jan 2015

      LONDON (Reuters) - Shire Plc has agreed to buy NPS Pharmaceuticals Inc for $5.2 billion in its biggest acquisition yet, as the Dublin-based drugmaker strengthens its position in the lucrative field of medicines for rare diseases.

    8. RPT-Shire to buy NPS Pharma for $5.2 bln

      Headlines

      Sun, 11 Jan 2015

      Jan 11 (Reuters) - Shire Plc said it will acquire NPS Pharmaceuticals Inc in an all-stock transaction for about $5.2 billion, the companies said in a joint statement on Sunday.

    9. CORRECTED-Shire to buy NPS Pharma for $5.2 bln

      Headlines

      Sun, 11 Jan 2015

      Jan 11 (Reuters) - Shire Plc said it will acquire NPS Pharmaceuticals Inc in an all-stock transaction for about $5.2 billion, the companies said in a joint statement on Sunday.

    10. Deals of the day- Mergers and acquisitions

      Headlines

      Mon, 5 Jan 2015

      (Adds NPS Pharmaceuticals , Revel Casino Hotel, Bang & Olufsen, Energy Fuels)

    « Prev1234Next »
    Content Partners